You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68Ga-DOTANOC

Showing 1 - 25 of 1,838
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumors Trial in Marseille ([68Ga]-DOTANOC PET/CT)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumors
  • [68Ga]-DOTANOC PET/CT
  • Marseille, France
    AP-HM
Oct 12, 2022

Patients With Gastroenteropancreatic Neuroendocrine Tumors Trial in France (68-Ga-DOTANOC)

Completed
  • Patients With Gastroenteropancreatic Neuroendocrine Tumors
  • Angers, France
  • +4 more
Jan 6, 2022

Intracranial Aneurysm, Cerebral Aneurysm, Inflammation Trial in Turku (PET imaging, 18F-FDG, PET imaging, 68Ga-DOTANOC)

Recruiting
  • Intracranial Aneurysm
  • +2 more
  • PET imaging, 18F-FDG
  • PET imaging, 68Ga-DOTANOC
  • Turku, Finland
    Turku University Hospital
Jan 14, 2021

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Tumor Positron-Emission Tomography Trial in Fuzhou (68Ga-DOTATATE and 68Ga-FAPI)

Recruiting
  • Tumor Positron-Emission Tomography
  • 68Ga-DOTATATE and 68Ga-FAPI
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 7, 2023

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis Trial in Xiamen (Drug: 68Ga-FAPI)

Recruiting
  • Spondyloarthritis
  • +2 more
  • Drug: 68Ga-FAPI
  • Xiamen, Fujian, China
    The first affiliated hospital of Xiamen University
Aug 13, 2023

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)

Recruiting
  • Myositis
  • Idiopathic Inflammatory Myopathies
  • Xiamen, Fujian, China
    The first affiliated hospital of Xiamen University
Jul 12, 2023

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

Recruiting
  • Adrenocortical Carcinoma
  • 68Ga-R8760 injection at pre-defined dose levels
  • 68GA-R8760 injection
  • Ann Arbor, Michigan
    University of Michigan Nuclear Medicine
Aug 11, 2023

Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)

Recruiting
  • Pancreatic Cancer
  • Cholangiocarcinoma
  • [68Ga]Ga-FAPI-46 PET/CT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Jul 13, 2023

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

Recruiting
  • Rectal Cancer
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 11, 2023

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

Completed
  • Neuroendocrine Tumors
  • Innsbruck, Austria
    Department of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Gastrointestinal Cancer Trial in Beijing (Intravenous injection of 68Ga-PMD22)

Recruiting
  • Gastrointestinal Cancer
  • Intravenous injection of 68Ga-PMD22
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jun 30, 2023

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Primary Sjögren Syndrome Trial (68Ga-P16-093)

Not yet recruiting
  • Primary Sjögren Syndrome
  • (no location specified)
Sep 19, 2023

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jul 4, 2023